C&EN16 天
Enantioselective Synthesis of Indole-Fused Polycycles Bearing Four Consecutive ...
Drug Discovery & Development Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China University of Chinese Academy of Sciences, Beijing 100049, China Drug ...
Pharmaceutical Technology1 个月
Nelfinavir mesylate by Pfizer for Relapsed Multiple Myeloma: Likelihood of Approval
Nelfinavir mesylate is under clinical development by Pfizer and currently in Phase I for Relapsed Multiple Myeloma. According to GlobalData, Phase I drugs for Relapsed Multiple Myeloma have a 71% ...